Touches on what subject? Someone said that the pill was being developed for Ulcerative Proctitis/Ulcerative Proctosigmoiditis. I said that "To my knowledge there has been zero discussion of a pill for Ulcerative Proctitis/Ulcerative Proctosigmoiditis", obviously (I would hope) referring to any discussion BY THE COMPANY.
The link that you provided has already been presented to refute my claim. It doesn't.
"Brilacidin is being developed as a novel, non-corticosteroid, non-biologic treatment, with formulation plans including.......oral tablets for Ulcerative Colitis and Crohn’s Disease,........and foam and/or gel for mild-to-moderate Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of IBD."
I added the dots since some seem to be having trouble separating the treatment forms and the indications.
If I'm wrong I know you'll correct me. If I'm right I'd appreciate it if you would confirm my understanding so I don't have to continue to defend it.
Market Data 
Markets 
AI
